Supply Chain

Under President Donald Trump's proposed 2018 budget, drug and device companies would have to pay almost twice as much for the Food and Drug Administration to review products, reports Reuters.

Hundreds of thousands of Americans with cancer delay filling prescriptions, cut pills in half or skip drug treatment altogether due to the exorbitant cost of new cancer drugs, reports Kaiser Health News.

Scott Gottlieb, MD, President Donald Trump's nominee to head the Food and Drug Administration, holds a diverse background in healthcare. He's previously worked as a deputy commissioner at the FDA, practiced medicine as a physician and served as a consultant…

Mylan settled a patent dispute with Roche Holding regarding a biosimilar version of Roche's successful breast cancer drug Herceptin, reports Reuters.

The Food and Drug Administration on Monday approved Novartis' experimental drug kisqali.

Allergan on Tuesday entered a research and development deal with Editas Medicine, reports Reuters.

Minnesota State Rep. Rod Hamilton, R- Mountain Lake, proposed legislation to limit pharmacy benefit manufacturer's ability to change a patient's drug treatments, according to the Star Tribune.

Hospitals are facing increasing pressure from CMS and commercial payers to lower spending while providing high-quality care amid the shift to value-based reimbursement. Leaders often turn to the supply chain, which represents one of the largest hospital expenses, to reduce…

While high prescription drug costs affect millions of Americans, and lawmakers are constantly working to tackle the issue, televised evening news programs rarely report on rising medication costs, according to a study from the progressive nonprofit research group Media Matters.

East Lansing-based Michigan State University partnered with the APICS Supply Chain Council to identify critical issues on the minds of supply chain leaders.